Asia-Pacific Molecular Diagnostics Market Assessment of 17 Countries-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

November 2021 | | ID: 24D51C7FF2C3EN
Venture Planning Group

Abstracts

This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and budget.

Highlights

• Supplier sales and market shares in major countries
• Five-year test volume and sales forecasts
• Strategic profiles of market players and start-up firms developing innovative technologies and products
• Emerging technologies
• Review of molecular diagnostic analyzers
• Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam

Market Segmentation Analysis

• Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.
• Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
• Five-year test volume and sales projections for over 30 NAT assays.
• A comprehensive analysis of the sequencing market, by country and laboratory segment, including:
  • Industrial
  • Academic
  • Government
  • Commercial
• Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.

Product/Technology Review

• Comparison of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
• Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.
• Universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

• Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
• Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. WORLDWIDE MARKET AND TECHNOLOGY REVIEW

A. DNA Sequencing
B. DNA and RNA Probe Technologies
C. Detection Technologies
D. Instrumentation
Review of latest analyzers from Abbott, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and other suppliers.
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
    Liquid Transportation and Mixing
    Separation
    Reaction
    Detection
F. Pharmacogenomics
G. Major Applications
  1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
    AIDS/HIV
    Adenovirus
    Aeromonads
    Anthrax/Bacillus Anthracis
    Arboviruses
    Babesiosis
    Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
    Blastocystis Hominis
    Brucella
    Campylobacter
    Candida
    Chagas Disease
    Chancroid
    Chlamydia
    Clostridium Difficile
    Coronaviruses
    Coxsackieviruses
    Creutzfeldt-Jakob’s Disease
    Cryptosporidium Parvum
    Cyclospora Cayetanensis
    Cytomegalovirus
    Ebola Virus
    E. Coli
    EchoVirus
    Encephalitis
    Enteroviruses
    Epstein-Barr Virus
    Giardia Lamblia
    Gonorrhea
    Granuloma Inguinale
    Hantavirus
    Helicobacter Pylori
    Hepatitis
    Herpes Simplex Virus
    Human Herpes Virus-6 (HHV-6)
    Influenza Viruses
    Legionella
    Lyme Disease
    Lymphogranuloma Venereum (LGV)
    Malaria
    Measles (Rubeola)
    Meningitis
    Microsporidium
    Mononucleosis
    Mumps
    Mycoplasma
    Papillomaviruses
    Parvovirus B19
    Pneumonia
    Polyomaviruses
    Pseudomonas Aeruginosa
    Rabies
    Respiratory Syncytial Virus (RSV)
    Rhinoviruses
    Rotavirus
    Rubella
    Salmonellosis
    Septicemia
    Shigellosis
    Staphylococcus Aureus
    Streptococci
    Syphilis
    Toxoplasmosis
    Trichomonas Vaginalis
    Tuberculosis
    Vibrio
    West Nile Virus
    Yersina
  2. Cancer Testing
    a. Overview
    b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
    c. Oncogenes
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
  3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal-Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
    c. DNA Profile Data Banks
    d. Judicial Implementation
    e. Major Crime Categories
    f. Factors Contributing to the DNA Probe Market Expansion
    Technology Availability
    Use of Hair as Evidence
    g. Wildlife Forensics
  5. Paternity Testing/HLA Typing
  6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/Complementing
  1. Monoclonal Antibodies/Immunoassays
  2. RNA Probes
  3. Two-Dimensional Electrophoresis
  4. Flow Cytometry

I. COUNTRY ANALYSES: VOLUME AND SALES FORECASTS--INFECTIOUS DISEASES, GENETIC DISEASES, CANCER, FORENSIC AND PATERNITY TESTING

    Australia
    Bangladesh
    China
    Hong Kong
    India
    Indonesia
    Japan
    Malaysia
    Myanmar
    New Zealand
    Pakistan
    Philippines
    Singapore
    South Korea
    Taiwan
    Thailand
    Vietnam
J. Competitive Assessments
The report provides strategic assessments of over 40 leading molecular diagnostics market players and start-up companies with innovative technologies and products, including:
Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, Wako and others.

VII. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING INNOVATIVE MOLECULAR DIAGNOSTIC TECHNOLOGIES AND PRODUCTS

List Of Tables

LIST OF TABLES

Australia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia
Molecular Diagnostics Test Volume Forecasts by Application
Australia
Major Infectious Disease Test Volume Forecasts by Assay
Australia
Molecular Diagnostics Market Forecasts by Application
Australia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Australia
Major Supplier Sales and Market Shares
Bangladesh
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bangladesh
Molecular Diagnostics Test Volume Forecasts by Application
Bangladesh
Major Infectious Disease Test Volume Forecasts by Assay
Bangladesh
Molecular Diagnostics Market Forecasts by Application
Bangladesh
Major Infectious Disease Diagnostics Market Forecasts by Assay
Bangladesh
Major Supplier Sales and Market Shares
China
Molecular Diagnostics Test Volume and Sales Forecasts by Application
China
Molecular Diagnostics Test Volume Forecasts by Application
China
Major Infectious Disease Test Volume Forecasts by Assay
China
Molecular Diagnostics Market Forecasts by Application
China
Major Infectious Disease Diagnostics Market Forecasts by Assay
China
Major Supplier Sales and Market Shares
Hong Kong
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hong Kong
Molecular Diagnostics Test Volume Forecasts by Application
Hong Kong
Major Infectious Disease Test Volume Forecasts by Assay
Hong Kong
Molecular Diagnostics Market Forecasts by Application
Hong Kong
Major Infectious Disease Diagnostics Market Forecasts by Assay
Hong Kong
Major Supplier Sales and Market Shares
India
Molecular Diagnostics Test Volume and Sales Forecasts by Application
India
Molecular Diagnostics Test Volume Forecasts by Application
India
Major Infectious Disease Test Volume Forecasts by Assay
India
Molecular Diagnostics Market Forecasts by Application
India
Major Infectious Disease Diagnostics Market Forecasts by Assay
India
Major Supplier Sales and Market Shares
Indonesia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Indonesia
Molecular Diagnostics Test Volume Forecasts by Application
Indonesia
Major Infectious Disease Test Volume Forecasts by Assay
Indonesia
Molecular Diagnostics Market Forecasts by Application
Indonesia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Indonesia
Major Supplier Sales and Market Shares
Japan
Molecular Diagnostics Test Volume and Sales by Major Application
Japan
Laboratories Performing DNA Sequencing by Market Segment
Japan
Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume by Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market by Major Application
Japan
Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market Estimated Sales by Major Supplier
Japan
Chlamydia Testing Market Estimated Sales by Major Supplier
Japan
CMV Testing Market Estimated Sales by Major Supplier
Japan
Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan
Herpes Testing Market Estimated Sales by Major Supplier
Japan
Meningitis Testing Market Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market Estimated Sales by Major Supplier
Japan
Shigella Testing Market Estimated Sales by Major Supplier
Malaysia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malaysia
Molecular Diagnostics Test Volume Forecasts by Application
Malaysia
Major Infectious Disease Test Volume Forecasts by Assay
Malaysia
Molecular Diagnostics Market Forecasts by Application
Malaysia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Malaysia
Major Supplier Sales and Market Shares
Myanmar
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Myanmar
Molecular Diagnostics Test Volume Forecasts by Application
Myanmar
Major Infectious Disease Test Volume Forecasts by Assay
Myanmar
Molecular Diagnostics Market Forecasts by Application
Myanmar
Major Infectious Disease Diagnostics Market Forecasts by Assay
Myanmar
Major Supplier Sales and Market Shares
New Zealand
Molecular Diagnostics Test Volume and Sales Forecasts by Application
New Zealand
Molecular Diagnostics Test Volume Forecasts by Application
New Zealand
Major Infectious Disease Test Volume Forecasts by Assay
New Zealand
Molecular Diagnostics Market Forecasts by Application
New Zealand
Major Infectious Disease Diagnostics Market Forecasts by Assay
New Zealand
Major Supplier Sales and Market Shares
Pakistan
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Pakistan
Molecular Diagnostics Test Volume Forecasts by Application
Pakistan
Major Infectious Disease Test Volume Forecasts by Assay
Pakistan
Molecular Diagnostics Market Forecasts by Application
Pakistan
Major Infectious Disease Diagnostics Market Forecasts by Assay
Pakistan
Major Supplier Sales and Market Shares
Philippines
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Philippines
Molecular Diagnostics Test Volume Forecasts by Application
Philippines
Major Infectious Disease Test Volume Forecasts by Assay
Philippines
Molecular Diagnostics Market Forecasts by Application
Philippines
Major Infectious Disease Diagnostics Market Forecasts by Assay
Philippines
Major Supplier Sales and Market Shares
Singapore
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Singapore
Molecular Diagnostics Test Volume Forecasts by Application
Singapore
Major Infectious Disease Test Volume Forecasts by Assay
Singapore
Molecular Diagnostics Market Forecasts by Application
Singapore
Major Infectious Disease Diagnostics Market Forecasts by Assay
Singapore
Major Supplier Sales and Market Shares
South Korea
Molecular Diagnostics Test Volume and Sales Forecasts by Application
South Korea
Molecular Diagnostics Test Volume Forecasts by Application
South Korea
Major Infectious Disease Test Volume Forecasts by Assay
South Korea
Molecular Diagnostics Market Forecasts by Application
South Korea
Major Infectious Disease Diagnostics Market Forecasts by Assay
South Korea
Major Supplier Sales and Market Shares
Taiwan
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Taiwan
Molecular Diagnostics Test Volume Forecasts by Application
Taiwan
Major Infectious Disease Test Volume Forecasts by Assay
Taiwan
Molecular Diagnostics Market Forecasts by Application
Taiwan
Major Infectious Disease Diagnostics Market Forecasts by Assay
Taiwan
Major Supplier Sales and Market Shares
Thailand
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Thailand
Molecular Diagnostics Test Volume Forecasts by Application
Thailand
Major Infectious Disease Test Volume Forecasts by Assay
Thailand
Molecular Diagnostics Market Forecasts by Application
Thailand
Major Infectious Disease Diagnostics Market Forecasts by Assay
Thailand
Major Supplier Sales and Market Shares
Vietnam
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Vietnam
Molecular Diagnostics Test Volume Forecasts by Application
Vietnam
Major Infectious Disease Test Volume Forecasts by Assay
Vietnam
Molecular Diagnostics Market Forecasts by Application
Vietnam
Major Infectious Disease Diagnostics Market Forecasts by Assay
Vietnam
Major Supplier Sales and Market Shares
Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests for Genetic Diseases